Navigation Links
Families Could Benefit From Gene Tests in Sudden Cardiac Death Victims
Date:11/15/2009

Identifying mutation in deceased cuts costs for evaluating risk in relatives, study shows

SUNDAY, Nov. 15 (HealthDay News) -- Genetic testing of people who've suffered sudden unexplained death is an effective and cost-efficient way of identifying genetic mutations that may put surviving relatives at increased risk for potentially deadly heart rhythm disturbances, a new study suggests.

Genetic defects that can cause sudden cardiac death occur in 25 percent to 30 percent of victims of sudden unexplained death. The current recommended approach is for first-degree relatives of sudden unexplained death victims to undergo comprehensive cardiac testing.

In this study, U.S. researchers compared the results and costs of postmortem genetic/molecular autopsy testing in 146 sudden unexplained death cases and found that 40 of the victims (26.7 percent) had either a catecholaminergic polymorphic ventricular tachycardia mutation (18 people) or a long QT syndrome mutation (22 people). Both are known to cause sudden death.

The researchers then estimated the costs of testing the 584 relatives of the sudden unexplained death victims. The total cost of postmortem genetic testing, genetic confirmation testing of the 160 relatives of victims who tested positive for mutations, and cardiac tests for both relatives of mutation-positive and mutation-negative sudden unexplained death victims was $6.78 million.

In comparison, comprehensive cardiac testing for all 584 relatives of the sudden unexplained death victims, followed by directed genetic testing, would have been more than $7.7 million.

"With less than 150 sudden unexplained death cases, use of a cardiac channel molecular autopsy would be estimated to save almost $1 million indicating a much less expensive way of evaluating those left behind," study co-author David Tester, a senior research technologist at Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minn., said in a news release.

"If you identify a mutation in a sudden unexplained death victim, you can do a simple genetic test in first-degree relatives to assess their risk and perform a disorder-directed clinical evaluation rather than a full clinical evaluation. If a relative is negative for the causative mutation, they may not need to undergo further clinical evaluation at all, and that saves money," Tester explained.

The study was to be presented Sunday at the American Heart Association's annual meeting in Orlando, Fla.

More information

The U.S. National Heart, Lung, and Blood Institute has more about sudden cardiac arrest.



-- Robert Preidt



SOURCE: American Heart Association, news release, Nov. 15, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. AMA Calls on Congress to Pass H.R. 3961, Access to Care for Seniors and Military Families at Stake
2. First Lady Michelle Obama, Dr. Jill Biden Join Blue Star Families, This Emotional Life Producers to Support Military Families
3. Mental Health America Partners With Prescription Audio To Donate $5M in PTSD Treatment Products to Veterans, Active Duty, Families, Providers
4. Minnesota Charity Launches Global Initiative to Help Children and Families Fighting Chronic Illnesses
5. Congress Encouraged to Protect Working Families and Flexible Spending Accounts in New Advertising Campaign
6. Nothing But Nets Delivers Anti-Malaria Nets to Children and Families in Uganda
7. Families Need to Know When Dementia Becomes Terminal
8. Shady Grove Fertility Center Presents 5K Fundraising Race to Help Families Afford Fertility Treatment or Adoption
9. New Families and Work Institute Study Reveals Declines in the Health of American Workforce
10. LYSOL(R) Launches Healthier Habits Rewards Program at Schools Nationwide to Help Protect Families from Germs, Such as H1N1
11. Compatible Technology International Project to Enhance Child Nutrition and Livelihoods of Rural Families in Malawi and Tanzania
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... Salucro, ... of the health care industry’s hospitals and provider groups, has announced that it ... select customers. Parasail Health is a San Francisco health-finance startup that has launched ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th ... to reach a staggering $6.81 billion by the year 2024 according to a new ... faster rate than those made from titanium. Los Angeles area clinic Beverly Hills Periodontics ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... expansion of Atmosera Managed Azure Services . The trusted, transparent, and secure ... of the company’s growing customer base. Atmosera’s next generation services include integrated capabilities ...
(Date:6/27/2017)... ... ... Today, June 27th is PTSD Awareness Day. Over half a million U.S. ... care due to lack of effective treatments, fear of stigma or insufficient government resources. ... veterans are at an increased risk for self-destructive behavior, including alcohol/drug abuse, depression, anxiety ...
(Date:6/26/2017)... ... June 26, 2017 , ... Torrance dentist, Dr. Robert ... be one of the most noticeable aspects of a person’s appearance. A healthy, radiant ... is born with beautiful, balanced teeth, everyone can have the smile of their dreams ...
Breaking Medicine News(10 mins):
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/24/2017)... , May 24, 2017  ivWatch LLC ... Equipment Manufacturer (OEM) Board to enable seamless integration ... patient monitoring systems, infusion pumps and other devices. ... will be able to help health care customers ... reduced risks related to IV therapy. ...
(Date:5/22/2017)... 22, 2017  As the specialty pharmacy industry ... to make the revolutionary shift from volume-based to ... ensuring positive patient outcomes and shaping the future ... focus away from clinical trials and toward data ... specialty drug therapy utilization in precise patient populations. ...
Breaking Medicine Technology: